Alpha Crest Capital Management LLC Invitae Corp Transaction History

Alpha Crest Capital Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$2.13 - $9.01 $251,772 - $1.07 Million	-118,203 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$6.28 - $15.59 $556,809 - $1.38 Million	88,664 Added 300.16%	118,203 $942,000
Q4 2021 Feb 09, 2022	BUY	$14.7 - $28.67 $247,533 - $482,774	16,839 Added 132.59%	29,539 $451,000
Q3 2021 Nov 10, 2021	BUY	$24.31 - $33.6 $308,737 - $426,720	12,700 New	12,700 $361,000
Q1 2021 May 13, 2021	SELL	$33.06 - $56.93 $499,206 - $859,643	-15,100 Closed	0 $0

Q4 2020 Feb 12, 2021	BUY	$39.09 - $57.4 $97,725 - $143,500	2,500 Added 19.84%	15,100 $631,000
Q3 2020 Nov 12, 2020	BUY	$28.43 - $44.67 $358,218 - $562,842	12,600 New	12,600 $546,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Alpha Crest Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Alpha Crest Capital Management LLC with notifications on news.